Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
U.S. drugmaker Pfizer and German biotech BioNTech said they began their late-stage human trial for a potential coronavirus vaccine on Monday as pharmaceutical companies race to win regulatory approval before the end of the year. Shares of Pfizer rose more than 3% in after-hours trading Monday. BioNTech was up more than 2%. The trial will include up… Read More »